Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Kupinsky Selling
View:
Post by DanKwong1958 on Nov 13, 2016 2:12pm

Kupinsky Selling

Putting aside what the bond market is saying on Concordia, the thing I find most diturbing is why the new Chairman sold half a million shares on Tuesday and there has been no buying by other insiders.   Trump is already backtracking on quashing Obamacare so I am comfortable with being in cash until I have more clarity.
Comment by greatplay on Nov 13, 2016 6:17pm
Good for you... Chairman sold before Trump won election, chairman may needed money urgerntly for personal affairs... Trump will never backtrack on Obamacare, it's the most important thing why he won elections... he promised to Obama to keep something from Obamacare, but he is in process of putting people who hate Obamacare, it's stupid to imagine that they will keep it... it's one ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities